Telephone
61.3.8060.6177
Address
Level 10 9 Yarra Street South Yarra, Victoria (VIC) 3141
Description
Alcidion Group Ltd. engages in the development and provision of healthcare software products marketed under the Miya, Patientrack, Smartpage and ExtraMed brands. It provides clinicians with decision support tools and making recommendations about patient care, patient flow and patient safety, organizational efficiency may be optimized and key clinical risks eliminated. It also offers solutions for Emergency Rooms, Inpatient Services and Outpatient Departments. The company was founded by Steven David Crabbe and Stephen James Woods on April 15, 2010 and is headquartered in South Yarra, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.04 - 0.13
Trade Value (12mth)
AU$26,001.00
1 week
32.73%
1 month
58.7%
YTD
-2.67%
1 year
-33.64%
All time high
0.48
EPS 3 yr Growth
-12.500%
EBITDA Margin
-3.80%
Operating Cashflow
$0m
Free Cash Flow Return
0.20%
ROIC
-3.90%
Interest Coverage
-12.30
Quick Ratio
1.00
Shares on Issue (Fully Dilluted)
1290m
HALO Sector
Technology
Next Company Report Date
28-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.02
Date | Announcements |
---|---|
25 July 24 |
Alcidion Quarterly Results and Investor Webcast Notification
×
Alcidion Quarterly Results and Investor Webcast Notification |
24 July 24 |
Alcidion Selected as Preferred EPR Supplier by North Cumbria
×
Alcidion Selected as Preferred EPR Supplier by North Cumbria |
17 July 24 |
Long term partnership signed with Hume Rural Health Alliance
×
Long term partnership signed with Hume Rural Health Alliance |
09 July 24 |
Notification of cessation of securities - ALC
×
Notification of cessation of securities - ALC |
03 May 24 |
Response to ASX Price Query
×
Response to ASX Price Query |
30 April 24 |
Change of Director's Interest Notice - D Sharp
×
Change of Director's Interest Notice - D Sharp |
24 April 24 |
Change of Director's Interest Notice - K Quirke
×
Change of Director's Interest Notice - K Quirke |
18 April 24 |
Q3 FY24 Quarterly Activities Report and Appendix 4C
×
Q3 FY24 Quarterly Activities Report and Appendix 4C |
12 April 24 |
Alcidion Quarterly Results and Investor Webcast Notification
×
Alcidion Quarterly Results and Investor Webcast Notification |
09 April 24 |
Notification of cessation of securities - ALC
×
Notification of cessation of securities - ALC |
06 March 24 |
Alcidion signs $3.4M contract extension with DGT NHS Trust
×
Alcidion signs $3.4M contract extension with DGT NHS Trust |
04 March 24 |
Becoming a substantial holder
×
Becoming a substantial holder |
28 February 24 |
Alcidion FY24 Appendix 4D and Half Year Report
×
Alcidion FY24 Appendix 4D and Half Year Report |
28 February 24 |
Investor Presentation - Half Year Results - H1 FY2024
×
Investor Presentation - Half Year Results - H1 FY2024 |
28 February 24 |
Alcidion H1 FY2024 Results
×
Alcidion H1 FY2024 Results |
22 February 24 |
Alcidion Half Year Results and Investor Webcast Notification
×
Alcidion Half Year Results and Investor Webcast Notification |
31 January 24 |
Q2 FY24 Quarterly Activities Report and Appendix 4C
×
Q2 FY24 Quarterly Activities Report and Appendix 4C |
24 January 24 |
Alcidion Quarterly Results and Investor Webcast Notification
×
Alcidion Quarterly Results and Investor Webcast Notification |
12 January 24 |
Notification of cessation of securities - ALC
×
Notification of cessation of securities - ALC |
11 December 23 |
ALC signs $23.3M South Tees contract extension until 2033
×
ALC signs $23.3M South Tees contract extension until 2033 |
08 December 23 |
Share Purchase Plan Closure and Results
×
Share Purchase Plan Closure and Results |
08 December 23 |
Application for quotation of securities - ALC
×
Application for quotation of securities - ALC |
22 November 23 |
Notification regarding unquoted securities - ALC
×
Notification regarding unquoted securities - ALC |
21 November 23 |
Extension of Share Purchase Plan Closing Date
×
Extension of Share Purchase Plan Closing Date |
21 November 23 |
Update - Proposed issue of securities - ALC
×
Update - Proposed issue of securities - ALC |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.